A Randomized, Double-blind, Placebo-controlled Study to Assess the Effects of Bempedoic Acid (ETC-1002) on the Occurrence of Major Cardiovascular Events in Patients with, or at high risk for, Cardiovascular Disease who are Statin Intolerant.

  • Dart, Anthony (Primary Chief Investigator (PCI))
  • Sally, Kay (Project Manager)

Project: Research

Project Details

StatusFinished
Effective start/end date23/11/18 → 23/04/22

Clinical Trial Phase

  • Phase III (a & b)